Company: HVIIR
Filing Date: 2025-12-23
Form Type: S-4
Source: 0001493152-25-029121
Chunk: 43

Company: Hennessy Capital Investment Corp. VII
Filing Date: 2025-12-23
Form: S-4
Chunk 43
---
II’s initial business combination
(subject to dollar-for-dollar reduction to the extent CCM’s Deferred Underwriting Commission is in excess of $2.0 million); (ii)
150,000 common shares (or equivalent equity) of the publicly listed post-business combination company (to be issued upon closing of HVII’s
initial business combination); and (iii) 5.0% of the gross proceeds raised from investors or other third parties identified by CCM and
received by HVII or the target upon closing of the PIPE Investment or other capital raising transaction.

Q. What conditions must be satisfied to complete the Business Combination?

A. There are a number of closing conditions in the Business Combination Agreement, including approval of the Transactions by the HVII Shareholders and ONE Nuclear Members. For a summary of the conditions that must be satisfied or waived prior to completion of the Business Combination, see the section of this proxy statement/prospectus entitled “ The Business Combination Agreement — Conditions to Closing; Termination — Conditions to Closing.” You should be aware that one or more of these conditions may be waived by a party to the Business Combination Agreement. For example, pursuant to the terms of the Business Combination Agreement, as a closing condition (subject to certain exceptions), the shares of New ONE Nuclear Common Stock to be issued in connection with the Business Combination are to be approved for listing on Nasdaq, but there can be no assurance that such listing condition will be met. If such listing condition is not met, the Business Combination will not be consummated unless the listing condition is waived by the parties to the Business Combination Agreement. Following the Closing, the shares of New ONE Nuclear Common Stock are intended to be listed, subject to Nasdaq approval, under the proposed symbol “ONEN.” It is important for you to know that, at the time of our extraordinary general meeting, we may not have received from Nasdaq either confirmation of the listing of the shares of New ONE Nuclear Common Stock or that approval will be obtained prior to the consummation of the Business Combination, and it is possible that the listing condition to the consummation of the Business Combination may be waived by the parties to the Business Combination Agreement. As a result, you may be asked to vote to approve the Business Combination and the other Proposals without such confirmation, and, further, it is possible that such confirmation may never be received and the Business Combination could still be consummated if such condition is waived or is subject to an exception and therefore the shares of New ONE Nuclear Common Stock would